Medical Devices Investors & VC Firms in Israel
104 firms in this list, with a median first check of $1M. 12 of them lead rounds. Generated from verified public data and updated continuously.
Vertex Ventures China
SingaporePre-Seed–Late Stage$2M – $85M
8 people
Kreos Capital
LondonSeries A–Late Stage
43 people
M Ventures
Los AngelesSeed–Growth$10.8M
6 people
Nina Capital
BarcelonaPre-Seed–Series A$215K – $1.6M
18 people
Samsung Ventures
SeoulSeed–Late Stage
26 people
Remiges Ventures, Inc.
SeattlePre-Seed–Seed
22 people
415 Capital
MunichSeries A–Late Stage$5.4M – $16.2M
15 people
Btomorrow Ventures
LondonSeed–Growth
18 people
Planven Entrepreneur Ventures
ZurichSeed–Late Stage$10M – $20M
20 people
Thorney Investment Group
MelbourneSeed–Late Stage
25 people
Accelmed Partners
MiamiPre-Seed–Late Stage
10 people
Pix Vine Capital
SingaporeSeed–Series A$250K – $500K
1 person
AMR Action Fund
BostonSeed–Series C
14 people
Supermoon Capital
San FranciscoPre-Seed–Series A$150K – $2.5M
7 people
Viola Credit
LondonPre-Seed–Late Stage$2M – $50M
14 people
3B Future Health Fund
MonacoPre-Seed–Late Stage$12M
12 people
Auriga Partners
ParisSeed–Growth$540K – $5.4M
15 people
Cross-Border Impact Ventures
TorontoSeries A–Series B$2M – $10M
12 people
Industrial Technology Investment Corporation
TaipeiSeed–Late Stage$1.9M – $227M
GEOC
ShanghaiSeed–Late Stage$3M – $10M
11 people
Laerdal Million Lives Fund
San FranciscoSeries A–Series B$1M – $5M
10 people
Star51 Capital
New York
16 people
Orbia Ventures
BostonSeed–Growth$1M – $6M
6 people
Panakes Partners
MilanSeed–Late Stage
13 people
Related lists
Investors & VC Firms in North America (14143)Investors & VC Firms in United States (13281)Investors & VC Firms in Europe (5575)Crypto & Web3 Investors & VC Firms (4830)Investors & VC Firms in Global (4158)SaaS Investors & VC Firms (3865)AI & Machine Learning Investors & VC Firms (3769)Fintech Investors & VC Firms (3726)Investors & VC Firms in Asia-Pacific (3574)Healthtech Investors & VC Firms (3415)
Data sourced from public filings and firms' own websites — see our methodology.
































































































